Tobias Martin Hohl MD
Assistant Professor, Medicine, University of Washington School of Medicine
Join to View Full Profile
530 East 74th StreetNew York, NY 10021
Dr. Hohl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2003 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2003
Weill Cornell MedicineClass of 2001
Certifications & Licensure
NY State Medical License 2002 - 2026
WA State Medical License 2008 - 2015
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- GM-CSF-mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to.Kathleen A M Mills, Frederike Westermann, Vanessa Espinosa, Eric Rosiek, Jigar V Desai
Science Immunology. 2025-03-21 - Evaluating the clinical utility of,andbronchoalveolar PCRs for the diagnosis of invasive pulmonary infections in patients with hematological malignancies.Varshini Gali, Rakan Al-Ghanamah, Katie Finnigan, Or Kalchiem-Dekel, Mini Kamboj
Journal of Clinical Microbiology. 2025-02-19 - Perforin-2 is dispensable for host defense againstand.Mariano A Aufiero, Li-Yin Hung, De'Broski R Herbert, Tobias M Hohl
Msphere. 2025-01-28
Journal Articles
- Response to Comment on “Sterilizing Immunity in the Lung Relies on Targeting Fungal Apoptosis-like Programmed Cell Death”Tobias Hohl, MD, Science Magazine
Press Mentions
Cancer Patients May Be at Greater Risk of Death from COVID-19October 4th, 2022- Dangerous Fungal Lung Infections Could Be Treated with CAR T-cellsSeptember 28th, 2022
- Antibiotics Induce Invasive Candidiasis in Mice and Humans, Immunotherapy Could HelpMay 16th, 2022
- Join now to see all
Grant Support
- Fungal Pathogenicity Determinants through the Lens of Immune-Targeted Cancer TherapiesDARTMOUTH COLLEGE2025–2030
- Understanding the molecular mechanisms regulating fungal colonization and disease in the mammalian intestinal nicheSLOAN-KETTERING INST CAN RESEARCH2024–2029
- INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSSLOAN-KETTERING INST CAN RESEARCH2011–2026
- INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSSLOAN-KETTERING INST CAN RESEARCH2011–2026
- INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSSLOAN-KETTERING INST CAN RESEARCH2011–2026
- INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSSLOAN-KETTERING INST CAN RESEARCH2011–2026
- 2025 Immunology of Fungal Infections Gordon Research Conference and Gordon Research SeminarGORDON RESEARCH CONFERENCES2024–2025
- 2025 Immunology of Fungal Infections Gordon Research Conference and Gordon Research SeminarGORDON RESEARCH CONFERENCES2024–2025
- 2025 Immunology of Fungal Infections Gordon Research Conference and Gordon Research SeminarGORDON RESEARCH CONFERENCES2024–2025
- 2025 Immunology of Fungal Infections Gordon Research Conference and Gordon Research SeminarGORDON RESEARCH CONFERENCES2024–2025
- Antifungal Immunity and the Mechanism of Fungal Programmed Cell DeathSLOAN-KETTERING INST CAN RESEARCH2019–2024
- Initiation Of The Immune Response To Aspergillus FumigatusNational Institute Of Allergy And Infectious Diseases2011
- Monocyte-Mediated Host Defense Against Aspergillus FumigatusNational Institute Of Allergy And Infectious Diseases2009–2010
- Monocyte-Mediated Host Defense Against Aspergillus FumigatusNational Institute Of Allergy And Infectious Diseases2008–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
